In the study performed by Zhai et al. in 2017, it was shown that the activation of the Kisspeptin-10 pathway suppresses VEGF secretion, and this provides a significant reduction in the clinical findings of OHSS [32]. The gene discussed is VEGFA; the disease is ovarian hyperstimulation syndrome.